REMINYL
Nomenclature and Context Reminyl is the proprietary trade name historically associated with the pharmaceutical compound galantamine hydrobromide, a drug primarily indicated for the symptomatic treatment of Alzheimer’s disease (AD). While generic formulations of galantamine are widely available today, the Reminyl brand remains significant in the history of AD pharmacotherapy. Chemically, galantamine is an alkaloid derived […]